ICP-490

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ICP-490, covering 2024-04-09 to 2025-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]

See pricing